United States · Funded startup

Who invested in Anebulo Pharmaceuticals

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$994Kraised across 1 round since 2025, from 1 source

Latest round
Grant, $994KSept 2025
Investors
0
See who backed them

The rounds

  1. Sept 2025
    Grant$994K

    No investor was named in the report.

    Source recorded

Funding filed with regulators

Anebulo Pharmaceuticals filed 3 raises, $25M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Dec 2024$15M1 investorSEC Form D
  2. Sept 2022$6.6M5 investorsequity, options, securities on exerciseof $16M offeredSEC Form D
  3. Jun 2020$3.0M1 investorequityof $5.3M offeredSEC Form D

Founders and team

From Anebulo Pharmaceuticals's own website: 2 on the team.

  • Daniel GeorgeTeam
  • Richie CunninghamTeam

Quick answers about Anebulo Pharmaceuticals

How much has Anebulo Pharmaceuticals raised?

Anebulo Pharmaceuticals has raised $994K across 1 round since 2025.

When did Anebulo Pharmaceuticals last raise?

Anebulo Pharmaceuticals's most recent round was a Grant of $994K in Sept 2025.

What was Anebulo Pharmaceuticals's biggest round?

Its most recent round, $994K in Sept 2025, is also its largest on record.

What stage is Anebulo Pharmaceuticals at?

Anebulo Pharmaceuticals's latest named round is a Grant, in Sept 2025.

Where is Anebulo Pharmaceuticals based?

Anebulo Pharmaceuticals is based in the United States.

Companies like Anebulo Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.